Cardiovascular disease and cancer are the leading causes of death in the U.S. and closely linked. Patients with cancer have increased risk of cardiovascular disease due to cardiac toxicities of some cancer therapies and shared risk factors between both conditions.
The Johns Hopkins Cardio-Oncology Program specializes in preventing and treating heart disease in patients undergoing cancer treatment and for cancer survivors.
The Johns Hopkins Cardio-Oncology Program brings together experts in the fields of cardiology and oncology to provide timely and specialized cardiovascular care to oncology patients and survivors of all ages. Our approach includes:
- Providing a comprehensive cardiovascular risk assessment for identification of cancer patients who are at high risk for suffering cardiac toxicities from cancer therapies
- The use of advance imaging for early identification of changes in cardiac function during cancer treatment
- Long term follow up of cancer survivors who received cardiotoxic treatments for early identification and management of cardiovascular disease
Our comprehensive assessment may include:
Highlighted ProgramCardiovascular Prevention for Breast Cancer Patients
Women diagnosed with breast cancer may experience heart disease during cancer treatments or many years into survivorship. Some studies suggest cardiovascular disease is the leading cause of mortality in survivors of breast cancer.
At Johns Hopkins we have a dedicated program for early identification and prevention of cardiovascular disease in persons with breast cancer. Through a comprehensive lifestyle and clinical assessment, blood work, and advanced imaging studies we provide an in depth overview of your cardiovascular risk coupled with life style counseling and medical optimization of cardiovascular risk factors.
Meet Our Experts
Marie (Dominique) Ashen, Ph.D, C.R.N.P
The Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
Kimberly Cuomo, M.S.N., C.R.N.P., C.H.F.N.